Article
An intranasal nanoparticle STING agonist has broad protective immunity against respiratory viruses and variants
2022-04-19
Abstract excerpt
Respiratory viral infections, especially Influenza (endemic) or SARS-CoV-2 (pandemic since 2020), cause morbidity and mortality worldwide. Despite remarkable progress in the development and deployment of vaccines, they are clearly impacted by the rapid emergence of viral variants. The development of an off-the-shelf, effective, safe, and low-cost drug for prophylaxis against respiratory viral infections is a major...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 783eed86-250f-58d1-b531-3fb3eb49a228
- DOI
- 10.1101/2022.04.18.488695
